Exploration of Alternative Therapies for the Management of Morphine Opioid Withdrawal Symptoms using Mitragyna s peciose Compound Compared with naloxone at the Mu Opioid Receptor: In Silico Approach and Molecular Docking

Authors

  • Tri Puji Lestari Sudarwati
  • Muhammad Sasmito Djati
  • Warsito Warsito
  • Sri Widyarti

Keywords:

Mitragyna speciosa, Opioid, Molecular Docking, In Silico, Abbreviations, Mu Opioid Receptor (MOR), Delta Opioid Receptor (DOR), and Kappa Opioid Receptor (KOR), Liquid Chromatography-Mass Spectrometry/ Mass Spectrometry (LC-MS/MS), ADMET (Absorption, Dist

Abstract

The current study elucidates the molecular pharmacodynamics of alkaloids derived from Mitragyna speciosa as candidates for mitigating opioid withdrawal symptoms, considering their interaction with the Mu Opioid Receptor (MOR). Employing an integrative in silico approach—including LC-MS/MS chemical profiling, ADMET prediction, molecular docking, and molecular dynamics simulation—we identified Corynoxine B as a lead compound exhibiting the most favorable binding affinity (-8.5 kcal/mol) relative to morphine and naloxone. Despite its superior affinity, Corynoxine B demonstrated comparatively lower structural stability in dynamic simulation, indicating the need for structural optimization. These findings suggest a differentiated interaction mechanism that could minimize conventional opioid side effects while maintaining therapeutic efficacy. Further in vivo and structure-activity relationship (SAR) studies are warranted to validate pharmacokinetics, receptor selectivity, and safety profiles. This work contributes to the rational development of plant-based modulators of MOR as novel alternatives or adjuncts in the clinical management of opioid dependence

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Alkassabi OY, Al- Sobayel H, Al-Eisa ES, Buragadda S, Alghadir AH, Iqbal A. Job satisfaction among physiotherapists in Saudi Arabia: Does the leadership style matter? BMC Health Serv Res. 2018;18(1):1–9.

Alva R. Job and career satisfaction among Indian physiotherapists: A preliminary survey. Int J Ther Rehabil . 2016;23(2).

Arif F. THE RELATIONSHIP BETWEEN ORGANIZATIONAL CITIZENSHIP BEHAVIOR AND JOB SATISFACTION AMONG PHYSIOTHERAPIST OF HOSPITALS OF KARACHI, PAKISTAN [Internet].

Avula, B., Sagi, S., Wang, Y. H., Wang, M., Ali, Z., Smillie, T. J., Zweigenbaum, J., & Khan, I. A. (2015). Identification and characterization of indole and oxindole alkaloids from leaves of Mitragyna speciosa Korth using liquid chromatography - Accurate QToF mass spectrometry. Journal of AOAC International , 98 (1), 13–21. https://doi.org/10.5740/jaoacint.14-110

Boffa, L., Ghè, C., Barge, A., Muccioli, G., & Cravotto, G. (2018). Alkaloid profiles and activity in different Mitragyna speciosa strains. Natural Product Communications , 13 (9), 1111–1116. https://doi.org/10.1177/1934578x1801300904

Brattig B, Scabbard A, The House A, Peter C. Occupational accident and disease claims, work related stress and job satisfaction of physiotherapists. Journal of Occupational Medicine and Toxicology. 2014 Jan;9(1)

Cornelissen, F.M.G., Markert, G., Deutsch, G., Antonara, M., Faaij, N., Bartelink, I., Noske, D., Vandertop, W.P., Bender, A., & Westerman, B.A. (2023). Explaining Blood-Brain Barrier Permeability of Small Molecules by Integrated Analysis of Different Transport Mechanisms. Journal of Medicinal Chemistry , 66 (11), 7253–7267. https://doi.org/10.1021/acs.jmedchem.2c01824

Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports , 7 (October 2016), 1–13. https://doi.org/10.1038/srep42717

de Sá, M. M., Pasqualoto, K. F. M., & Rangel-Yagui, C. de O. (2010). A 2D-QSPR approach to predict blood-brain barrier penetration of drugs acting on the central nervous system. Brazilian Journal of Pharmaceutical Sciences , 46 (4), 741–751. https://doi.org/10.1590/s1984-82502010000400016

Dixit A, Madan M, Goswami SK, Professor A, Deendayal P, Delhi N, et al. DIFFICULTIES EXPERIENCED BY OCCUPATIONAL THERAPISTS AND PHYSICAL THERAPISTS AT THE BEGINNING OF THEIR CAREER

Frenny FC, Balaji S, Anusuya A. A SURVEY ON LEVEL OF JOB SATISFACTION AMONG DIFFERENT

Gupta N, Joshi S. Predictors of Job Satisfaction among Physiotherapy Professionals. Indian Journal of Physiotherapy and Occupational Therapy - An International Journal. 2013;7(3):146.

Hanapi, NA, Chear, NJY, Azizi, J., & Yusof, SR (2021). Kratom Alkaloids: Interactions With Enzymes, Receptors, and Cellular Barriers. Frontiers in Pharmacology , 12 (November), 1–21. https://doi.org/10.3389/fphar.2021.751656

Hassan, Z., Muzaimi, M., Navaratnam, V., Yusoff, NHM, Suhaimi, FW, Vadivelu, R., Vicknasingam, BK, Amato, D., von Hörsten, S., Ismail, NIW, Jayabalan, N., Hazim, AI, Mansor, SM, & Müller, CP (2013). From Kratom to mitragynine and its derivatives: Physiological and behavioral effects related to use, abuse, and addiction. Neuroscience and Biobehavioral Reviews , 37 (2), 138–151. https://doi.org/10.1016/j.neubiorev.2012.11.012

Iliopoulos E, Morrissey N, Baryeh K, Polyzois I. Correlation between workplace learning and job satisfaction of NHS healthcare professionals [Internet]. Vol. 24, English Journal of Healthcare Management. 2018. Available from: www.bjhcm.co.uk

IN INDIA-A CROSS SECTIONAL STUDY [Internet]. Peers Reviewed and Referee Journal. 2021. Available from: http://ijmer.in/pdf/e-Certificate%20of%20Publication-IJMER.pdf

International Research Journal of Modernization in Engineering Technology and Science www.irjmets.com @International Research Journal of Modernization in Engineering. 2032. p. 2582–5208. Available from: www.irjmets.com

Karunakaran, T., Ngew, KZ, Zailan, AAD, Mian Jong, VY, & Abu Bakar, MH (2022). The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review. Frontiers in Pharmacology , 13 (February), 1–11. https://doi.org/10.3389/fphar.2022.805986

Kowalczuk, A.P., Lozak, A., & Zjawiony, J.K. (2013). Comprehensive methodology for identification of Kratom in police laboratories. Forensic Science International , 233 (1–3), 238–243. https://doi.org/10.1016/j.forsciint.2013.09.016

Kruegel, A.C., & Grundmann, O. (2018). The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. In Neuropharmacology (Vol. 134). Elsevier Ltd. https://doi.org/10.1016/j.neuropharm.2017.08.026

Latzke M, Putz P, Kulnik ST, Schlegl C, Sorge M, Mériaux -Kratochvila S. Physiotherapists' job satisfaction according to employment situation: Findings from an on line survey in Austria. Physiotherapy Research International. 2021 Jan;26(3).

León, F., Obeng, S., Mottinelli, M., Chen, Y., King, T.I., Berthold, C., Kamble, S.H., Restrepo, L.F., Patel, A., Gamez-jimenez, L.R., Lopera-londoño, C., Hiranita, T., Sharma, A., & Hampson, A.J. (nd). Supplemental Materials Activity of .

Martini, L., & Whistler, J. L. (2007). The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Current Opinion in Neurobiology , 17 (5), 556–564. https://doi.org/10.1016/j.conb.2007.10.004

Matsumoto, K., Yamamoto, L.T., Watanabe, K., Yano, S., Shan, J., Pang, PKT, Ponglux, D., Takayama, H., & Horie, S. (2005). Inhibitory effect of mitragynine, an analgesic alkaloid from Thai herbal medicine, on neurogenic contraction of the vas deferens. Life Sciences , 78 (2), 187–194. https://doi.org/10.1016/j.lfs.2005.04.042

Meylani, V., Rizal Putra, R., Miftahussurur, M., Sukardiman, S., Eko Hermanto, F., & Abdullah, A. (2023). Molecular docking analysis of Cinnamomum zeylanicum phytochemicals against Secreted Aspartyl Proteinase 4–6 of Candida albicans as anti-candidiasis oral. Results in Chemistry , 5 (December 2022), 100721. https://doi.org/10.1016/j.rechem.2022.100721

Pires, DEV, Blundell, T.L., & Ascher, D.B. (2015). pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry , 58 (9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104

Prozialeck, W. C., Jivan, J. K., & Andurkar, S. V. (2012). Pharmacology of Kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects. Journal of the American Osteopathic Association , 112 (12), 792–799.

Raini, M. (2017). Kratom (Mitragyna speciosa Korth): Benefits, Side Effects and Legality. Health Research and Development Media . https://doi.org/10.22435/mpk.v27i3.6806.175-184

Ramanathan, S., & McCurdy, C.R. (2020). Kratom (Mitragyna speciosa): Worldwide issues. Current Opinion in Psychiatry , 33 (4), 312–318. https://doi.org/10.1097/YCO.0000000000000621

Rodarte, J.V., Baehr, C., Hicks, D., Liban, T.L., Weidle, C., Rupert, P.B., Jahan, R., Wall, A., McGuire, A.T., Strong, R.K., Runyon, S., Pravetoni, M., & Pancera, M. (2023). Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding. Structure , 31 (1), 20-32.e5. https://doi.org/10.1016/j.str.2022.11.008

Shahida, N. (2024). Indonesian Journal of Chemical Science Kratom (Mitragyna speciosa): Medicinal Marvel or Menace? Assessing Potency, Risk, and Future Prospect of Herbal Medicine . 13 (1).

Shaik Mossadeq, WM, Sulaiman, MR, Tengku Mohamad, TA, Chiong, HS, Zakaria, ZA, Jabit, ML, Baharuldin, MTH, & Israf, DA (2009). Anti-inflammatory and antinociceptive effects of Mitragyna speciosa Korth methanolic extract. Medical Principles and Practice , 18 (5), 378–384. https://doi.org/10.1159/000226292

Singh, D., Müller, C. P., & Vicknasingam, B. K. (2014). Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence , 139 , 132–137. https://doi.org/10.1016/j.drugalcdep.2014.03.017

Spielvogel, C.P., Schindler, N., Schröder, C., Stellnberger, S.L., Wadsak, W., Mitterhauser, M., Papp, L., Hacker, M., Pichler, V., & Vraka, C. (2025). Enhancing Blood-Brain Barrier Penetration Prediction by Machine Learning-Based Integration of Novel and Existing, In Silico and Experimental Molecular Parameters from a Standardized Database. Journal of Chemical Information and Modeling . https://doi.org/10.1021/acs.jcim.4c02212

Suhaimi, F.W., Yusoff, N.H.M., Hassan, R., Mansor, S.M., Navaratnam, V., Müller, C.P., & Hassan, Z. (2016). Neurobiology of Kratom and its main alkaloid mitragynine. Brain Research Bulletin , 126 , 29–40. https://doi.org/10.1016/j.brainresbull.2016.03.015

Swogger, M. T., & Walsh, Z. (2018). Kratom use and mental health: A systematic review. Drug and Alcohol Dependence , 183 (October 2017), 134–140. https://doi.org/10.1016/j.drugalcdep.2017.10.012

Takayama, H., Ishikawa, H., Kurihara, M., Kitajima, M., Aimi, N., Ponglux, D., Koyama, F., Matsumoto, K., Moriyama, T., Yamamoto, L.T., Watanabe, K., Murayama, T., & Horie, S. (2002). Studies on the synthesis and opioid agonistic activities of mitragynine-related indole alkaloids: Discovery of opioid agonists structurally different from other opioid ligands. Journal of Medicinal Chemistry , 45 (9), 1949–1956. https://doi.org/10.1021/jm010576e

Tang, F., Ng, C.M., Bada, H.S., & Leggas, M. (2021). Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments. Clinical and Translational Science , 14 (4), 1231–1249. https://doi.org/10.1111/cts.12994

Váradi, A., Marrone, GF, Palmer, TC, Narayan, A., Szabó, MR, Le Rouzic, V., Grinnell, SG, Subrath, JJ, Warner, E., Kalra, S., Hunkele, A., Pagirsky, J., Eans, SO, Medina, JM, Xu, J., Pan, YX, Borics, A., Pasternak, GW, McLaughlin, J. P., & Majumdar, S. (2016). Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2. Journal of Medicinal Chemistry , 59 (18), 8381–8397. https://doi.org/10.1021/acs.jmedchem.6b00748

Veeramohan, R., Azizan, KA, Aizat, WM, Goh, HH, Mansor, SM, Yusof, NSM, Baharum, SN, & Ng, CL (2018). Metabolomics data of Mitragyna speciosa leaf using LC-ESI-TOF-MS. Data in Brief , 18 , 1212–1216.

WORKING ORGANIZATIONS. IJRAR19J1702 International Journal of Research and Analytical Reviews (IJRAR) www.ijrar.org [Internet]. 2019;334. Available from: www.ijrar.org

.

Downloads

Published

2025-05-21

How to Cite

1.
Sudarwati TPL, Djati MS, Warsito W, Widyarti S. Exploration of Alternative Therapies for the Management of Morphine Opioid Withdrawal Symptoms using Mitragyna s peciose Compound Compared with naloxone at the Mu Opioid Receptor: In Silico Approach and Molecular Docking. J Neonatal Surg [Internet]. 2025May21 [cited 2025Sep.24];14(26S):217-29. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/6260

Issue

Vol. 14 No. 26S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.